The stock may react positively to the dividend increase and buyback, but the opioid settlement is a major overhang. Traders should watch for the market's reaction to the settlement's impact on future cash flow and debt levels.
Price Chart
Executive Summary
Albertsons reported mixed results: strong adjusted earnings beat and raised dividend, but a massive $774M opioid settlement charge caused a net loss. The company also increased its share buyback authorization.
Key Financial Metrics
Key Facts
- Reported adjusted EPS of $0.48, beating consensus of $0.44.
- Announced a $774 million opioid settlement, resulting in a $600 million net loss.
- Increased quarterly dividend by 13% to $0.17 per share.
- Raised remaining share repurchase authorization to $2 billion.
Financial Impact
The $774M opioid settlement charge is a significant one-time expense, but the core business remains profitable with a strong adjusted earnings beat. The dividend increase signals confidence in future cash flow.
Risk Factors
- The $774M opioid settlement could strain future cash flow and increase debt.
- The settlement is a significant liability that could impact future financial flexibility.
- The company's future performance is uncertain given the settlement and ongoing litigation risks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001646972-26-000028 |
| Exhibit: ex992-opioid.htm | 0001646972-26-000028 |
| Exhibit: ex993-dividendrelease.htm | 0001646972-26-000028 |
| Document: aci-20260414.htm | 0001646972-26-000028 |
| Document: 0001646972-26-000028-index-headers.html | 0001646972-26-000028 |
| Document: 0001646972-26-000028-index.html | 0001646972-26-000028 |
| Document: 0001646972-26-000028.txt | 0001646972-26-000028 |
| 8-K Data (Synthetic) | 0001646972-26-000028 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | 3 | $12.08 $12.35 | ▲ +2.24% | ▲ +2.46% | $11.75 (−2.73%) |
Sep 9, 2026 23d ago | 8-K | $11.85 $12.82 | ▲ +8.14% | ▲ +8.48% | $11.75 (−0.84%) |
Aug 26, 2026 5w ago | Court Ruling | $12.40 $12.48 | ▼ −0.65% | ▼ −0.77% | $11.75 (+5.24%) |
Aug 12, 2026 7w ago | Institutional Cluster | $12.01 $12.12 | ▼ −0.92% | ▼ −1.36% | $11.75 (+2.16%) |
Aug 11, 2026 7w ago | Court Ruling | $12.25 $12.21 | ▼ −0.33% | ▲ +0.08% | $11.75 (−4.08%) |
Aug 3, 2026 8w ago | Insider Cluster | $12.07 $12.25 | ▲ +1.49% | ▲ +1.59% | $11.75 (−2.65%) |
Jul 30, 2026 9w ago | Insider Cluster | $11.60 $12.08 | ▲ +4.14% | ▲ +0.52% | $11.75 (+1.29%) |
Jul 23, 2026 10w ago | 8-K | $11.44 $11.60 | ▼ −1.40% | ▼ −0.92% | $11.75 (−2.71%) |
Jul 23, 2026 10w ago | 8-K | $11.44 $11.60 | ▲ +1.40% | ▲ +0.92% | $11.75 (+2.71%) |
Jul 9, 2026 12w ago | Court Ruling | $14.34 $15.02 | ▲ +4.74% | ▲ +4.87% | $11.75 (−18.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access